Extracellular Vesicles in Psychiatry Research in the Context of RDoC Criteria

키워드

참고문헌 (79)

1. Conigliaro A, "Exosomes: nanocarriers of biological messages", Adv Exp Med Biol, 998, pp.23~43 (2017)
2. Paolicelli RC, "Cell-to-cell communication by extracellular vesicles: focus on microglia", Neuroscience (2018)
3. Tietje A, "Cerebrospinal fluid extracellular vesicles undergo age dependent declines and contain known and novel non-coding RNAs", PLoS ONE, 9, pp.e113116~ (2014)
4. Crescitelli R, "Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes", J Extracell Vesicles, 2 (2013)
5. Minciacchi VR, "Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes", Semin Cell Dev Biol, 40, pp.41~51 (2015)
6. Huotari J, "Endosome maturation", EMBO J, 30, pp.3481~3500 (2011)
7. Ha D, "Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges", Acta Pharm Sin B, 6, pp.287~296 (2016)
8. Akers JC, "Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies", J Neurooncol, 113, pp.1~11 (2013)
9. Rajagopal C, "The origin and functions of exosomes in cancer", Front Oncol, 8, pp.66~ (2018)
10. Xu W, "From pathogenesis to clinical application: insights into exosomes as transfer vectors in cancer", J Exp Clin Cancer Res, 35, pp.156~ (2016)
11. Lobb RJ, "Optimized exosome isolation protocol for cell culture supernatant and human plasma", J Extracell Vesicles, 4, pp.27031~ (2015)
12. Theodoraki MN, "Separation of plasmaderived exosomes into CD3((+)) and CD3((-)) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients", Clin Exp Immunol, 192, pp.271~283 (2018)
13. Carpintero-Fernández P, "Technical advances to study extracellular vesicles", Front Mol Biosci, 4, pp.79~ (2017)
14. Banfer S, "Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion", Proc Natl Acad Sci U S A, 115, pp.E4396~E4405 (2018)
15. Merchant ML, "Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery", Nat Rev Nephrol, 13, pp.731~749 (2017)
16. Bekelis K, "Frameless robotically targeted stereotactic brain biopsy: feasibility, diagnostic yield, and safety", J Neurosurg, 116, pp.1002~1006 (2012)
17. Albrecht DS, "In Vivo Imaging of Human Neuroinflammation", ACS Chem Neurosci, 7, pp.470~483 (2016)
18. Fabi A, "Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases", Transl Lung Cancer Res, 5, pp.637~646 (2016)
19. Ferezou I MF, "In Vivo Optical Imaging of Brain Function", pp.2009, CRC Press
20. Arboix A, "Complementary examinations other than neuroimaging and neurosonology in acute stroke", World J Clini Cases, 5, pp.191~202 (2017)
21. Borroto-Escuela DO, "The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural-glial networks", Philos Trans R Soc Lond B Biol Sci, 370 (2015)
22. Doherty CM, "Diagnostic lumbar puncture", Ulster Med J, 83, pp.93~102 (2014)
23. Di Terlizzi R, "The function, composition and analysis of cerebrospinal fluid in companion animals: part I-function and composition", Vet J, 172, pp.422~431 (2006)
24. Narahari A, "MicroRNAs as biomarkers for psychiatric conditions: a review of current research", Innov Clin Neurosci, 14, pp.53~55 (2017)
25. Andras IE, "Extracellular vesicles of the blood-brain barrier", Tissue Barriers, 4, pp.e1131804~ (2016)
26. Matsumoto J, "The transport mechanism of extracellular vesicles at the blood-brain barrier", Curr Pharm Des, 23, pp.6206~6014 (2017)
27. Smalheiser NR., "Do neural cells communicate with endothelial cells via secretory exosomes and microvesicles?", Cardiovasc Psychiatry Neurol, 2009, pp.383086~ (2009)
28. Mustapic M, "Plasma extracellular vesicles enriched for neuronal origin:a potential window into brain pathologic processes", Front Neurosci, 11, pp.278~ (2017)
29. Fauré J, "Exosomes are released by cultured cortical neurones", Mol Cel Neurosci, 31, pp.642~648 (2006)
30. Kanninen KM, "Exosomes as new diagnostic tools in CNS diseases", Biochim Biophys Acta, 1862, pp.403~410 (2016)
31. Potolicchio I, "Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism", J Immunol, 175, pp.2237~2243 (2005)
32. Kramer-Albers EM, "Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons?", Proteomics Clin Appl, 1, pp.1446~1461 (2007)
33. Gallart-Palau X, "Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR", Mol Neurodegener, 11, pp.41~ (2016)
34. Raghavan V., "Role of exosomes in psychiatric disorders", Asian J Psychiatr, 28, pp.78~79 (2017)
35. Masdeu JC, "Neuroimaging in psychiatric disorders", Neurotherapeutics, 8, pp.93~102 (2011)
36. The Lancet Psychiatry, "Blood biomarkers in psychiatry", Lancet Psychiatry, 3, pp.693~ (2016)
37. Hiemke C, "Clinical utility of drug measurement and pharmacokinetics:therapeutic drug monitoring in psychiatry", Eur J Clin Pharmacol, 64, pp.159~166 (2008)
38. Banigan MG, "Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients", PLoS One, 8, pp.e48814~ (2013)
39. Brites D, "Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation", Front Cell Neurosci, 9, pp.476~ (2015)
40. Choi JL, "miR-149 and miR-29c as candidates for bipolar disorder biomarkers", Am J Med Genet B Neuropsychiatr Genet, 174, pp.315~323 (2017)
41. Pegtel DM, "Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain", Philos Trans R Soc Lond B Biol Sci, 369 (2014)
42. Sawa A., "Innovative Medicine: Basic Research and Development", pp.157~163 (2015), Springer
43. Jacob KS, "Depression: a major public health problem in need of a multi-sectoral response", Indian J Med Res, 136, pp.537~539 (2012)
44. Kaiser RH, "Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity", JAMA Psychiatry, 72, pp.603~611 (2015)
45. Zhang HF, "Neuroimaging genomic studies in major depressive disorder: a systematic review", CNS Neurosci Ther (2018)
46. Woody ML, "Integrating NIMH Research Domain Criteria (RDoC) into depression research", Curr Opin Psychol, 4, pp.6~12 (2015)
47. Singhal G, "Microglia: an Interface between the loss of neuroplasticity and depression", Front Cell Neurosci, 11, pp.270~ (2017)
48. Kim YK, "Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression", Prog Neuropsychopharmacol Biol Psychiatry, 70, pp.117~126 (2016)
49. Kim YK, "The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression", Prog Neuropsychopharmacol Biol Psychiatry, 64, pp.277~284 (2016)
50. Lopez JP, "Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response", Curr Opin Psychiatry, 31, pp.7~16 (2018)
51. Woelfer M, "The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder", Neuroscience (2018)
52. Ogasawara K, "Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5", J Neural Transm (Vienna), 125, pp.211~222 (2018)
53. Nusslock R, "Reward processing and mood-related symptoms:An RDoC and translational neuroscience perspective", J Affect Disord, 216, pp.3~16 (2017)
54. Cosgrove VE, "Toward a valid animal model of bipolar disorder: how the research domain criteria help bridge the clinical-basic science divide", Biol Psychiatry, 79, pp.62~70 (2016)
55. Rolls ET, "Limbic systems for emotion and for memory, but no single limbic system", Cortex, 62, pp.119~157 (2015)
56. Ikemoto S, "Basal ganglia circuit loops, dopamine and motivation: a review and enquiry", Behavioural brain research. Behav Brain Res, 290, pp.17~31 (2015)
57. Rong H, "MicroRNA-134 plasma levels before and after treatment for bipolar mania", J Psychiatr Res, 45, pp.92~95 (2011)
58. Luarte A, "Astrocytes at the hub of the stress response: potential modulation of neurogenesis by miRNAs in astrocyte-derived exosomes", Stem Cells Int, 2017, pp.1719050~ (2017)
59. Picchioni MM, "Schizophrenia", BMJ, 335, pp.91~95 (2007)
60. Debnath M, "Fetal programming of schizophrenia: select mechanisms", Neurosci Biobehav Rev, 49, pp.90~104 (2015)
61. Patel KR, "Schizophrenia: overview and treatment options", P T, 39, pp.638~645 (2014)
62. Faludi G, "Synaptic changes in the brain of subjects with schizophrenia", Int J Dev Neurosci, 29, pp.305~309 (2011)
63. Barch DM, "Behavioral Neuroscience of Motivation", pp.411~449 (2016), Springer International Publishing
64. Ford JM, "Studying Hallucinations Within the NIMH RDoC Framework", Schizophr Bull, 40(Suppl 4), pp.S295~S304 (2014)
65. Nascimento Juliana M, "Proteomics and molecular tools for unveiling missing links in the biochemical understanding of schizophrenia", Proteomics Clin Appl, 10, pp.1148~1158 (2016)
66. Suire CN, "Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles", Exp Gerontol, 98, pp.209~216 (2017)
67. Pituch KC, "Dysfunction of platelet-derived growth factor receptor alpha (PDGFRalpha)represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells", J Biol Chem, 290, pp.7040~7053 (2015)
68. Kumar K, "Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease", Biomed Pharmacother, 98, pp.297~307 (2018)
69. Weller J, "Current understanding of Alzheimer’s disease diagnosis and treatment", F1000Res, 7, pp.F1000~ (2018)
70. Craft S., "The role of metabolic disorders in Alzheimer’s disease and vascular dementia: two roads converged?", Arch Neurol, 66, pp.300~305 (2009)
71. Giri M, "Genes associated with Alzheimer’s disease: an overview and current status", Clin Interv Aging, 11, pp.665~681 (2016)
72. Guedes JR, "Roles of microglial and monocyte chemokines and their receptors in regulating Alzheimer’s disease-associated amyloid-beta and Tau pathologies", Front Neurol, 9, pp.549~ (2018)
73. Lanctôt KL, "Neuropsychiatric signs and symptoms of Alzheimer’s disease: New treatment paradigms", Alzheimers Dement (N Y), 3, pp.440~449 (2017)
74. Xiao T, "The role of exosomes in the pathogenesis of Alzheimer’ disease", Transl Neurodegener, 6, pp.3~ (2017)
75. Nhan HS, "The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes", Acta Neuropathol, 129, pp.1~19 (2015)
76. Frost GR, "The role of astrocytes in amyloid production and Alzheimer’s disease", Open Biol, 7 (2017)
77. Mudher A, "What is the evidence that tau pathology spreads through prion-like propagation?", Acta Neuropathol Commun, 5, pp.99~ (2017)
78. Yuyama K, "Exosomes as carriers of Alzheimer’s Amyloidss", Front Neurosci, 11, pp.229~ (2017)
79. Chen JJ, "Potential roles of exosomal microRNAs as diagnostic biomarkers and therapeutic application in Alzheimer’s disease", Neural Plasticity, 2017, pp.7027380~ (2017)

관련 논문AI추천